D. Torres

发表

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Joel Z Stengel, Christopher D. Williams, Michael Asike, 2011, Gastroenterology.

Nonalcoholic fatty liver disease.

D. Torres, S. Harrison, M. Hjelkrem, 2020, Minerva medica.

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

J. Albrecht, K. Koury, H. Tillmann, 2010, Hepatology.

Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12‐month randomized, prospective, open‐ label trial

Christopher D. Williams, D. Torres, J. Shaw, 2011, Hepatology.

Noninvasive methods of assessing nonalcoholic fatty liver disease: what the clinician needs to know.

D. Torres, S. Harrison, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Current treatments in nonalcoholic steatohepatitis

D. Torres, S. Harrison, 2007, Current treatment options in gastroenterology.

The Pointy End of the NAFLD Iceberg: Cirrhosis, Portal Hypertension, and Liver Failure

D. Torres, S. Harrison, Jonathon W. Schwake, 2013 .

Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease

D. Torres, S. Harrison, Maryam R. Kashi, 2008, Seminars in liver disease.

Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association?

D. Torres, S. Harrison, R. Kwok, 2013, Hepatology.

Extrahepatic Manifestations of Hepatitis C Virus Infection: Mixed Cryoglobulinemia and Beyond

D. Torres, A. Paredes, 2011 .

Editorial: Killing Two Birds With One Stone: Screening for Chronic Hepatitis C at the Time of Colonoscopy in the Baby Boomer Cohort

D. Torres, S. Harrison, 2013, The American Journal of Gastroenterology.

Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis

Christopher D. Williams, D. Torres, S. Harrison, 2012, Hepatology.

Physical activity: an essential component of lifestyle modification in NAFLD

D. Torres, S. Harrison, B. Rodriguez, 2012, Nature Reviews Gastroenterology &Hepatology.

Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial

Christopher D. Williams, D. Torres, J. Shaw, 2013, Therapeutic advances in gastroenterology.

NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis

D. Torres, S. Harrison, 2013, Nature Reviews Gastroenterology &Hepatology.

Chapter 28 – Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

D. Torres, S. Harrison, 2010 .

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Manfred von der Ohe, A. Coates, C. Trautwein, 2019, The Lancet.

Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle

D. Torres, S. Harrison, 2012, Hepatology.

Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis

D. Torres, S. Harrison, 2015, Hepatology.

Nonalcoholic fatty liver disease: is it all in the genes?

D. Torres, S. Harrison, 2010, Hepatology.

Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series

N. Chalasani, D. Torres, S. Harrison, 2010, The American Journal of Gastroenterology.

Is it time to write a prescription for coffee? Coffee and liver disease.

D. Torres, S. Harrison, 2013, Gastroenterology.

Wilson’s Disease and Iron Overload: Pathophysiology and Therapeutic Implications

M. Canevari, D. Torres, Brett W. Sadowski, 2021, Clinical liver disease.

Current Treatments in Current Treatments in Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis

D. Torres, S. Harrison, 2007 .

Effect of Weight Loss on Nonalcoholic Fatty Liver Disease

D. Torres, S. Harrison, Anish A. Patel, 2009, Journal of clinical gastroenterology.

Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.

J. Chan, D. Rockey, P. Thuluvath, 2020, Journal of Hepatology.

HCV Replication and Statin Pleotropism: An Adjuvant Treatment Panacea?

D. Torres, S. Harrison, 2008, The American Journal of Gastroenterology.

Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise

D. Torres, S. Harrison, A. Paredes, 2012, Clinical liver disease.

Nutrition in cirrhosis and chronic liver disease.

D. Torres, S. Harrison, Wassem Y. Juakiem, 2014, Clinics in liver disease.

Features, diagnosis, and treatment of nonalcoholic fatty liver disease.

D. Torres, S. Harrison, C. D. Williams, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Vitamin D and NAFLD : Is it More Than Just an Association ?

D. Torres, S. Harrison, R. Kwok, 2013 .

Occult HBV Infection: A Case Series at a Military Treatment Facility.

D. Torres, Sarah Ordway, Kevin Pak, 2020, Military medicine.

Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).

D. Torres, Brett W. Sadowski, J. Shumar, 2019, ACG case reports journal.

Small steps toward a better treatment for chronic hepatitis C infection: mericitabine, pegylated interferon, and ribavirin in the PROPEL and JUMP‐C trials

D. Torres, S. Harrison, 2013, Hepatology.

Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label study.

E. Lawitz, D. Torres, S. Harrison, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Update on Specifically Targeted Antiviral Therapy for Hepatitis C Infection: Progress and Pitfalls on the Road to Viral Eradication

D. Torres, 2010 .

Diagnosis and therapy of nonalcoholic steatohepatitis.

D. Torres, S. Harrison, Stephen A. Harrison, 2008, Gastroenterology.

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients with Nonalcoholic Steatohepatitis With Cirrhosis And Portal Hypertension.

H. Conjeevaram, N. Chalasani, D. Rockey, 2019, Gastroenterology.

Chronic HCV and Steatosis

D. Torres, S. Harrison, 2012 .

Hepatitis C eradication with sofosbuvir leads to significant metabolic changes

Amilcar L. Morales, D. Torres, M. Sjogren, 2016, World journal of hepatology.

Nonalcoholic fatty liver disease.

D. Torres, S. Harrison, A. Paredes, 2008, Clinics in liver disease.